TRCT
VXRT

Tower Research Capital (TRC)’s Vaxart VXRT Stock Holding History

Tower Research Capital (TRC)’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,806
Closed -$5.34K – 5677
2025
Q2 		$5.34K Buy
11,806
+4,155
+54% +$1.81K ﹤0.01% 4204
2025
Q1 		$3.11K Buy
7,651
+3,339
+77% +$2.14K ﹤0.01% 4465
2024
Q4 		$2.85K Sell
4,312
-1,536
-26% -$1.07K ﹤0.01% 4763
2024
Q3 		$4.96K Buy
5,848
+1,914
+49% +$1.46K ﹤0.01% 4359
2024
Q2 		$2.62K Sell
3,934
-27,906
-88% -$23.2K ﹤0.01% 4983
2024
Q1 		$41.4K Buy
31,840
+17,219
+118% +$18K ﹤0.01% 2409
2023
Q4 		$8.38K Buy
14,621
+2,983
+26% +$2.06K ﹤0.01% 4515
2023
Q3 		$8.78K Buy
11,638
+1,020
+10% +$776 ﹤0.01% 4307
2023
Q2 		$7.75K Sell
10,618
-4,956
-32% -$4.61K ﹤0.01% 4532
2023
Q1 		$12K Buy
15,574
+7,034
+82% +$6.53K ﹤0.01% 4133
2022
Q4 		$9K Sell
8,540
-78,533
-90% -$111K ﹤0.01% 4282
2022
Q3 		$190K Buy
87,073
+51,953
+148% +$179K ﹤0.01% 1987
2022
Q2 		$123K Buy
35,120
+21,642
+161% +$80.8K ﹤0.01% 2129
2022
Q1 		$68K Sell
13,478
-15,633
-54% -$79.2K ﹤0.01% 2494
2021
Q4 		$182K Sell
29,111
-22,390
-43% -$153K ﹤0.01% 1845
2021
Q3 		$410K Buy
51,501
+43,524
+546% +$358K 0.01% 1145
2021
Q2 		$60K Buy
7,977
+1,462
+22% +$10.2K ﹤0.01% 2881
2021
Q1 		$39K Sell
6,515
-67,136
-91% -$516K ﹤0.01% 3340
2020
Q4 		$420K Buy
73,651
+40,618
+123% +$258K 0.01% 1127
2020
Q3 		$219K Buy
33,033
+18,165
+122% +$162K ﹤0.01% 2492
2020
Q2 		$132K Buy
+14,868
New +$42.7K 0.01% 2205
2019
Q1 		– Sell
-250
Closed – – 4326
2018
Q4 		$0 Buy
+250
New +$744 ﹤0.01% 4416
2017
Q3 		– Sell
-4,471
Closed -$33K – 4176
2017
Q2 		$33K Buy
4,471
+4,162
+1,347% +$24.9K ﹤0.01% 963
2017
Q1 		$2K Buy
309
+243
+368% +$2.49K ﹤0.01% 2673
2016
Q4 		$1K Sell
66
-350
-84% -$5.34K ﹤0.01% 3669
2016
Q3 		$9K Sell
416
-1,401
-77% -$22.2K ﹤0.01% 2165
2016
Q2 		$28K Buy
1,817
+1,305
+255% +$21.7K ﹤0.01% 1983
2016
Q1 		$8K Buy
512
+445
+664% +$7.94K ﹤0.01% 2251
2015
Q4 		$1K Sell
67
-1,232
-95% -$27K ﹤0.01% 4176
2015
Q3 		$28K Buy
1,299
+1,288
+11,709% +$31.2K ﹤0.01% 1461
2015
Q2 		$0 Buy
+11
New +$270 ﹤0.01% 5084
2014
Q4 		– Sell
-63
Closed -$2K – 4746
2014
Q3 		$2K Buy
+63
New +$1.81K ﹤0.01% 3884
2014
Q2 		– Sell
-142
Closed -$10K – 4695
2014
Q1 		$10K Buy
142
+106
+294% +$6.56K ﹤0.01% 2625
2013
Q4 		$2K Buy
+36
New +$1.58K ﹤0.01% 4058
2013
Q3 		– Sell
-78
Closed -$3K – 4882
2013
Q2 		$3K Buy
+78
New +$3.24K ﹤0.01% 3335

Other funds holding VXRT

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
CFO
Custos Family Office Austin, Texas $147M AUM 17.83% 1-Year Est. Return
LCM
LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Tower Research Capital (TRC)'s VXRT Position: Q3 2025 in Review

Tower Research Capital (TRC) sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 11,806 shares — an estimated $5.34K sold.

Tower Research Capital (TRC) first reported a position in VXRT in Q2 2013 and held it in 35 quarters. The position peaked at $420K in Q4 2020. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Tower Research Capital (TRC) reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 11,806 Vaxart shares in Q3 2025, an estimated $5.34K.
  • Tower Research Capital (TRC) first reported a position in Vaxart in Q2 2013 and held it in 35 quarters.
  • Tower Research Capital (TRC)'s Vaxart position peaked at $420K in Q4 2020.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.